ExodusPoint Capital Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-40,561
Closed -$3.45M 2575
2020
Q3
$3.45M Sell
40,561
-6,026
-13% -$305K 0.07% 250
2020
Q2
$1.65M Buy
+46,587
New +$1.36M 0.04% 506
2019
Q4
Sell
-19,906
Closed -$264K 2042
2019
Q3
$264K Buy
+19,906
New +$293K 0.01% 959

ExodusPoint Capital Management's IMMU Position: Q4 2020 in Review

ExodusPoint Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 40,561 shares — an estimated $3.45M sold.

ExodusPoint Capital Management first reported a position in IMMU in Q3 2019 and held it in 3 quarters. The position peaked at $3.45M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • ExodusPoint Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • ExodusPoint Capital Management sold 40,561 Immunomedics Inc shares in Q4 2020, an estimated $3.45M.
  • ExodusPoint Capital Management first reported a position in Immunomedics Inc in Q3 2019 and held it in 3 quarters.
  • ExodusPoint Capital Management's Immunomedics Inc position peaked at $3.45M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.